½ÃÀ庸°í¼­
»óǰÄÚµå
1304641

¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀå : ±â¼úº°, ¹æÃâ ¸ÞÄ¿´ÏÁòº°, ¿ëµµº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2023-2030³â)

Control Release Drug Delivery Market with COVID-19 Impact Analysis, By Technology, By Release Mechanism, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: AnalystView Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® 300 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

º¸°í¼­ÀÇ ÁÖ¿ä ³»¿ë

2022³â ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀå ±Ô¸ð´Â 520¾ï 170¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç 2023³âºÎÅÍ 2030³â±îÁö CAGR 10.8%·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹æÃâ Á¦¾îÇü ¾à¹° Àü´Þ ½ÃÀå - ½ÃÀå ¿ªÇÐ :

¼¼°è ³ë·ÉÀα¸ ¹× ¾Æµ¿Àα¸ Áõ°¡¿¡ µû¸¥ ¼ö¿ä Áõ°¡

ÀÌ ¿¬·É´ë¿¡¼­´Â ¾à¹° Ä¡·á ºÒº¹Á¾ÀÌ ¸Å¿ì ÈçÇÕ´Ï´Ù. ¶ÇÇÑ ³ëÀÎ Àα¸´Â ½ÅüÀû, »ý¹°ÇÐÀû, Á¤½ÅÀû ±â´ÉÀÌ ÀúÇÏµÇ¾î ¾à¹° ¼·Ãë·®¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¶ÇÇÑ ³ëÀÎÀÇ ½Åü´Â ¾à¹°ÀÇ ºÎÀÛ¿ë°ú °í¿ë·®À» °ßµô ¼ö ¾ø½À´Ï´Ù. µû¶ó¼­ ȯÀÚ ¼ö°¡ ±ÞÁõÇÔ¿¡ µû¶ó ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª Á¤ºÎÀÇ ¾ö°ÝÇÑ ±ÔÁ¦¿Í º¹ÀâÇÑ Á¦Á¶ ÀýÂ÷°¡ Á¦¾î ¹æÃ⠾๰ Àü´Þ ½ÃÀåÀÇ ¼ºÀåÀ» ÀúÇØÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ³·Àº º¹¿ë·®, ¾à¹°ÀÇ È¿´É°ú ¾ÈÀü¼º Çâ»ó, ºÎÀÛ¿ë ÃÖ¼ÒÈ­, ¾à¹°ÀÇ ¾ÈÁ¤¼º Çâ»ó µîÀº ¹æÃâ Á¦¾î ¾à¹° Àü´ÞÀÇ ÀåÁ¡À¸·Î ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¦¾î ¹æÃ⠾๰ Àü´Þ ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®:

  • ´ç»çÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®°¡ °øÀ¯ÇÑ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀåÀº ¿¹Ãø ±â°£(2023-2030) µ¿¾È ¾à 10.8%ÀÇ CAGR·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ³ë·ÉÀα¸¿Í ¼Ò¾Æ Àα¸ Áõ°¡·Î ÀÎÇØ ¾à¹° ¹æÃâ Á¦¾îÇü ¾à¹° Àü´Þ »ê¾÷Àº ºü¸¥ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ±â¼ú ¼¼ºÐÈ­¿¡ µû¶ó 2022³â¿¡´Â Ç¥Àû Àü´ÞÀÌ °¡Àå ³ôÀº ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
  • ¹æÃâ ¸ÞÄ¿´ÏÁòÀÇ ¼¼ºÐÈ­¿¡ µû¸£¸é, Çǵå¹é Á¦¾î ¾à¹° Àü´Þ ½Ã½ºÅÛÀº 2022³â ÁÖ¿ä À¯ÇüÀ̾ú½À´Ï´Ù.
  • Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2022³â ¸ÅÃâÀ» ÁÖµµÇß½À´Ï´Ù.

¹æÃâÁ¦¾îÇü ¾à¹°Àü´Þ ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

¼¼°è ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀåÀº ±â¼ú, ¹æÃâ ¸ÞÄ¿´ÏÁò, ±â¼ú ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

±â¼úÀº °æÇÇ, ¿ì½ºÅ͹ý, Äھº£À̼Ç, ÀÓÇöõÆ®, Ç¥Àû Àü´Þ, ¸¶ÀÌÅ©·Î ĸ½¶È­, ±âŸ µî 6°¡Áö·Î ºÐ·ùµË´Ï´Ù. Ç¥Àû Àü´Þ ºÎ¹®ÀÌ °¡Àå Å« ¸ÅÃâ ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ³ëÀÎ Àα¸¿Í ¼Ò¾Æ Àα¸ Áõ°¡·Î ÀÎÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ÀÌ ºÎ¹® ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ç¥Àû Àü´ÞÀº ÀÛ¿ë ºÎÀ§¸¦ Á¦°øÇÏ°í ±âÁ¸ Àü´Þ ½Ã½ºÅÛ¿¡ ºñÇØ ¾à¹° µ¶¼ºÀ» À¯¹ßÇÒ ¼ö ÀÖ´Â ºÎÀ§¿¡¼­ ¾à¹°À» ¸Ö¸® ¶³¾î¶ß¸± ¼ö ÀÖ½À´Ï´Ù.

ÀÌ ½ÃÀåÀº ¹æÃâ ¸ÞÄ¿´ÏÁò¿¡ µû¶ó ¸¶ÀÌÅ©·Î ÀúÀå¼Ò ÆÄƼ¼Ç Á¦¾î ¾à¹° Àü´Þ ½Ã½ºÅÛ, È­ÇÐÀûÀ¸·Î Ȱ¼ºÈ­µÈ ¾à¹° Àü´Þ ½Ã½ºÅÛ, Çǵå¹é Á¦¾î ¾à¹° Àü´Þ ½Ã½ºÅÛ, Ȱ¼ºÈ­ Á¶Àý ¾à¹° Àü´Þ ½Ã½ºÅÛ, °íºÐÀÚ ±â¹Ý ¾à¹° Àü´Þ ½Ã½ºÅÛ, °íºÐÀÚ ±â¹Ý ¾à¹° Àü´Þ ½Ã½ºÅÛÀÇ ´Ù¼¸ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ½Ã½ºÅÛ, Çǵå¹é Á¦¾î ¾à¹° Àü´Þ ½Ã½ºÅÛ, Ȱ¼ºÈ­ Á¶Àý ¾à¹° Àü´Þ ½Ã½ºÅÛ, °íºÐÀÚ ±â¹Ý ½Ã½ºÅÛ µî 5°¡Áö·Î ºÐ·ùµË´Ï´Ù. Çǵå¹é Á¦¾î ¾à¹° Àü´Þ ½Ã½ºÅÛÀº ´ç´¢º´À» Æ÷ÇÔÇÑ Áúº´ Ä¡·á¿¡¼­ ³ôÀº Ä¡·á È¿À²·Î ÀÎÇØ ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ¶ÇÇÑ, Çǵå¹é Á¦¾î ¾à¹° Àü´Þ ½Ã½ºÅÛÀÇ ÀáÀç·ÂÀ» Ȱ¿ëÇϱâ À§ÇÑ ¿¬±¸°³¹ß Ȱµ¿ÀÌ È°¹ßÈ÷ ÁøÇàµÇ°í ÀÖ´Ù´Â Á¡µµ ½ÃÀå È®´ë¿¡ ÈûÀ» ½Ç¾îÁÖ°í ÀÖ½À´Ï´Ù.

ÀÌ ½ÃÀåÀº ¿ëµµº°·Î ÁÖÀÔ ÆßÇÁ, Á¤·®Àû ÈíÀÔ±â, °æÇÇ ¹× ¾È°ú¿ë ÆÐÄ¡, °æ±¸ ¾à¹° Àü´Þ ½Ã½ºÅÛ, ÁÖ»çÁ¦, ¾à¹° ¿ëÃâ ½ºÅÙÆ® µî 6°¡Áö Ä«Å×°í¸®·Î ºÐ·ùµË´Ï´Ù. °æ±¸¿ë ¾à¹°Àü´Þ½Ã½ºÅÛÀº ³ôÀº °¡¿ë¼º°ú »ç¿ë ºóµµ·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¶ÇÇÑ, ¿¹Ãø ±â°£ µ¿¾È ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ¶Ç ´Ù¸¥ À¯¸®ÇÑ ºÎ¹®Àº Á¤·® Åõ¿© ÈíÀÔ±âÀÔ´Ï´Ù. È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡, ±â¼ú ¹ßÀü ¹× ºó¹øÇÑ Á¦Ç°ÀÌ ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀå - Áö¸®Àû ÅëÂû·Â:

Áö¿ªÀûÀ¸·Î ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«·Î ³ª´¹´Ï´Ù. ÀÌ Áö¿ªÀº ºñÁî´Ï½º¸¦ °¡Á® ¿À´Â ±¹°¡¿¡ µû¶ó ´õ ¼¼ºÐÈ­µË´Ï´Ù.

¹æÃâÁ¦¾îÇü ¾à¹°Àü´Þ ½ÃÀå - °æÀï »óȲ:

¸¹Àº ±â¾÷µéÀÌ ¹æÃâ Á¦¾î¸¦ º¸ÀåÇϱâ À§ÇØ ´Ù¾çÇÑ ±â¼úÀ» »ç¿ëÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä Á¦¾à»çµéµµ ¹æÃâ Á¦¾î¸¦ ÅëÇØ Á¦Ç° º¸±Þ°ú ¼ÒºñÀÚ ±â¹ÝÀ» È®´ëÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. µû¶ó¼­ ½ÃÀå¿¡´Â ´Ù¸¥ ±â¾÷¿Í ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷ µî ´Ù¾çÇÑ ±â¾÷ÀÌ Á¸ÀçÇϸç Ä¡¿­ÇÑ °æÀï¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ÁøÃâ±â¾÷µéÀº ±âÁ¸ Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ È®ÀåÇϱâ À§ÇØ R&D Ȱµ¿, °øµ¿ ¿¬±¸, ÀμöÇÕº´, ÆÄÆ®³Ê½ÊÀ» ÃßÁøÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 3¿ù ¿¡º¸´ÐÀº ÀǾàǰ Ȱ¼º ¼ººÐÀÇ ¿ëÇØ¼ºÀ» °³¹ßÇϱâ À§ÇØ °æ±¸¿ë ÀǾàǰÀÇ »õ·Î¿î ¹Ì¸³ÀÚ ±â¼úÀÎ EUDRATEC(R) SoluFlow¸¦ ¹ßÇ¥ÇÏ¿´½À´Ï´Ù. ¶ÇÇÑ, EUDRATEC SoluFlow´Â ½Å±Ô ÀúºÐÀÚÀÇ 70% ÀÌ»óÀÌ ºÒ¿ë¼ºÀ̱⠶§¹®¿¡ ¾Ï, ½ÉÇ÷°ü Áúȯ, ´ç´¢º´, °¨¿° µî ´Ù¾çÇÑ Áõ»ó¿¡ ´ëÇÑ »õ·Î¿î °æ±¸¿ë Ä¡·áÁ¦¸¦ °³¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÃÖ±ÙÀÇ ¿òÁ÷ÀÓ

¿¹¸¦ µé¾î, 2021³â 1¿ù, TAPEMARK¿Í BIOTTS´Â °íºÐÀÚ °æÇÇ ¾à¹° Àü´ÞÀ» À§ÇÑ MACROPERM(TM)À» °³¹ßÇϱâ À§ÇØ Á¦ÈÞ¸¦ ¸Î¾ú½À´Ï´Ù. ¶ÇÇÑ, ÇǺθ¦ ÅëÇØ API(¿ø·áÀǾàǰ)¸¦ ¿î¹ÝÇϵµ·Ï ¼³°èµÈ »õ·Î¿î °íºÐÀÚ °æÇÇ ±â¼úÀÔ´Ï´Ù.

Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

ÀÌ Á¶»ç º¸°í¼­´Â ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀå ½ÃÀå ±Ô¸ð, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR%), 2022³âÀ» ±âÁØ¿¬µµ·Î ÇÑ ÃßÁ¤ ¹× ¿¹Ãø(2023-2030³â)À» Á¦°øÇÕ´Ï´Ù.

ÀÌ Á¶»ç º¸°í¼­´Â °í°´¿¡°Ô ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀå¿¡ ´ëÇÑ ÃֽŠÃֽе¿Çâ¿¡ ´ëÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.

ÀÌ Á¶»ç º¸°í¼­´Â ´Ù¾çÇÑ ºÎ¹®/±¹°¡¿¡ °ÉÃÄ ÀáÀçÀûÀÎ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

ÀÌ º¸°í¼­´Â »õ·Î¿î ÅõÀÚ ±âȸ, ±âÁ¸ ±â¾÷ÀÌ Á÷¸éÇÑ µµÀü °úÁ¦, ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀå¿¡¼­ Áö¼Ó °¡´ÉÇÑ ¼ºÀå ¿äÀÎÀ» ÆÄ¾ÇÇÕ´Ï´Ù.

Äڷγª19°¡ ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀå ±Ô¸ð, ¿¹Ãø, CAGR ¹× ½ÃÀå ¿ªÇп¡ ¹ÌÄ¡´Â ¿µÇâÀº ¿¬±¸ ¹üÀ§¿¡¼­ ÀÚ¼¼È÷ ³íÀǵǸç, COVID ÀÌÈÄ ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀå¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·Âµµ ´Ù·ç°í ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â »ç¿ëÀÚ¿¡°Ô ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ °üÁ¡À» Á¦°øÇϱâ À§ÇØ ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀå °æÀï ±¸µµ¿Í ÁÖ¿ä Çõ½Å°¡ ºÐ¼®µµ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ½ÃÀå ±Ô¸ð, ¼ºÀå·ü, ¸Å·Âµµ¸¦ ±âÁØÀ¸·Î ¸ðµç »ê¾÷ ºÎ¹®À» º¥Ä¡¸¶Å·ÇÑ ¼ºÀå Àü¸Á ¸ÅÇÎ ºÐ¼®À» Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀå¿¡¼­ Ȱµ¿ÇÏ´Â ±â¾÷ÀÇ À繫 Á¤º¸¿Í Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê¸¦ ÀÌÇØÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â ÁÖ¿ä ½ÃÀå Âü¿©ÀÚ¸¦ Áß½ÉÀ¸·Î »ó¼¼ÇÑ ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» Á¦°øÇÕ´Ï´Ù.

¶ÇÇÑ, ÀÌ º¸°í¼­´Â ¼¼°è»Ó¸¸ ¾Æ´Ï¶ó Áö¿ªÀû Â÷¿ø¿¡¼­µµ ÁÖ¿ä ½ÃÀå Âü¿©ÀÚµéÀÇ Áß¿äÇÑ ÀμöÇÕº´, Á¦ÈÞ ¹× ÇÕÀÛÅõÀÚ, ½ÅÁ¦Ç° Ãâ½Ã, ¿¬±¸°³¹ß, Áö¿ªÀû ÁøÃâ µîÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖµµ·Ï Çß½À´Ï´Ù.

ÀÌ Á¶»ç º¸°í¼­´Â ÁÖ·Î °ø±Þ¾÷ü, ÅõÀÚÀÚ, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À¯Åë ¾÷ü, ±ÝÀ¶ ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ °ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀå °³¿ä

  • Á¶»ç ¹üÀ§
  • ½ÃÀå ÃßÁ¤ ¿¬¼ö

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ³»¿ª
  • °æÀï ÀλçÀÌÆ®

Á¦3Àå ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ÁÖ¿ä ½ÃÀå µ¿Çâ

  • ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀå ±âȸ
  • ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀå ÇâÈÄ µ¿Çâ

Á¦4Àå ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ¾÷°è Á¶»ç

  • PEST ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • ¼ºÀå Àü¸Á ¸ÅÇÎ
  • ±ÔÁ¦ ±¸Á¶ ºÐ¼®

Á¦5Àå ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

  • ½ÅÇü Äڷγª¹ÙÀÌ·¯½º ÀÌÀüÀÇ ¿µÇ⠺м®
  • ½ÅÇü Äڷγª¹ÙÀÌ·¯½º ÀÌÈÄÀÇ ¿µÇ⠺м®

Á¦6Àå ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀå ±¸µµ

  • ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â
  • ÁÖ¿ä Á¦Á¶¾÷üº° ºÐ¼® µ¥ÀÌÅÍ
    • È®¸³µÈ ±â¾÷ ºÐ¼®
    • ½Å±Ô ±â¾÷ ºÐ¼®

Á¦7Àå ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀå - ±â¼úº°

  • °³¿ä
    • ±â¼úº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • Transdermal
    • Wurster Technique
    • Coacervation
    • Implants
    • Targeted Delivery
    • Micro Encapsulation
    • ±âŸ

Á¦8Àå ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀå - ¹æÃâ ¸ÞÄ¿´ÏÁòº°

  • °³¿ä
    • ¹æÃâ ¸ÞÄ¿´ÏÁòº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • ¸¶ÀÌÅ©·Î ¸®Àú¹ö ÆÄƼ¼Ç Á¦¾î ¾à¹°Àü´Þ ½Ã½ºÅÛ
    • È­ÇРȰ¼ºÈ­
    • Çǵå¹é ±ÔÁ¦ ¾à¹°Àü´Þ ½Ã½ºÅÛ
    • Ȱ¼ºÈ­ Á¶Àý ¾à¹°Àü´Þ ½Ã½ºÅÛ
    • Æú¸®¸Ó ±â¹Ý ½Ã½ºÅÛ

Á¦9Àå ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀå - ¿ëµµº°

  • °³¿ä
    • ¿ëµµº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • ÁÖÀÔ ÆßÇÁ
    • Á¤·® ÈíÀÔ±â
    • °æÇÇÆÐÄ¡ ¹× ´«ÆÐÄ¡
    • °æ±¸ Á¦¾î ¾à¹°Àü´Þ ½Ã½ºÅÛ
    • ÁÖ»ç °¡´É
    • ¾à¹° ¿ëÃâ ½ºÅÙÆ®

Á¦10Àå ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ½ÃÀå - Áö¿ªº°

  • ¼­·Ð
  • ºÏ¹Ì
    • °³¿ä
    • ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ºÏ¹Ì ÁÖ¿ä Á¦Á¶¾÷ü
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • °³¿ä
    • ¹æÃâ Á¦¾î ¾à¹° Àü´Þ À¯·´ ÁÖ¿ä Á¦Á¶¾÷ü
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ·¯½Ã¾Æ
    • ³×´ú¶õµå
    • ½º¿þµ§
    • Æú¶õµå
    • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç(APAC)
    • °³¿ä
    • ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ¾Æ½Ã¾ÆÅÂÆò¾ç ÁÖ¿ä Á¦Á¶¾÷ü
    • Àεµ
    • Áß±¹
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • ű¹
    • Àεµ³×½Ã¾Æ
    • Çʸ®ÇÉ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • °³¿ä
    • ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ¶óƾ¾Æ¸Þ¸®Ä« ÁÖ¿ä Á¦Á¶¾÷ü
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • °³¿ä
    • ¹æÃâ Á¦¾î ¾à¹° Àü´Þ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ÁÖ¿ä Á¦Á¶¾÷ü
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ÅÍŰ
    • ¾ËÁ¦¸®
    • ÀÌÁýÆ®
    • ±âŸ

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® - ¹æÃâ Á¦¾î ¾à¹° Àü´Þ ¾÷°è

  • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ °³¿ä
    • Adare Pharma Solutions
    • Orbis Biosciences, Inc.
    • Alkermes plc
    • Capsugel
    • Johnson and Johnson
    • Colorcon
    • GlaxoSmithKline
    • Coating Place, Inc.
    • Merck and Co., Inc.
    • Corium International, Inc.
    • Lonza
    • Pfizer, Inc
    • Aradigm Corporation
    • Depomed, Inc.
    • The Danfoss Group

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ ´Ù°¢Àû °ßÇØ

LSH 23.08.16

REPORT HIGHLIGHT

Control release drug delivery Market size was valued at USD 52,001.7 Million in 2022, expanding at a CAGR of 10.8% from 2023 to 2030.

Controlled-release drug delivery is used as a dosage form that transfers a medication or drug in a predetermined manner. Additionally, a drug delivery system offers regular delivery of medication or drugs in predictable kinetics in the whole course of gastrointestinal transit for the predetermined time. Moreover, the drug is released until it reaches a particular target in the GI tract. Further, systems of control release drug delivery use drug encapsulating devices from which the medication or drug is released at a rate that is managed for a noticeably long period, ranging from days to months.

Control Release Drug Delivery Market- Market Dynamics:

Increasing geriatric and pediatric populations worldwide increasing demand

Among these age groups, non-adherence to the medicine regimen is very common. In addition, geriatric populations undergo compromised physical, biological, and mental functions that affect their medicine intake. Moreover, their body cannot tolerate the harsh side-effects of drugs and high doses. This, in turn, increases the demand for controlled-release drug delivery systems with a steeply rising patient population. However, strict government regulations and complicated manufacturing procedures are prime factors that are expected to slow down the market growth of controlled-release drug delivery. Furthermore, lower dose requirements, improved drug efficacy and safety, minimum side effects, and improved stability of the drug are such advantages of control release drug delivery which further projected to drive market growth.

Control Release Drug Delivery Market- Key Insights:

  • As per the analysis shared by our research analyst, the global control release drug delivery market is estimated to grow annually at a CAGR of around 10.8% over the forecast period (2023-2030)
  • The Control release drug delivery industry is projected to grow at a significant rate due to the increasing geriatric and pediatric population
  • Based on technology segmentation, targeted delivery was predicted to show maximum market share in the year 2022
  • Based on release mechanism segmentation, feedback-regulated drug delivery systems was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Control Release Drug Delivery Market- Segmentation Analysis:

The global control release drug delivery market is segmented on the basis of technology, release mechanism, technology, and region.

The market is divided into six categories based on technology: transdermal, wurster technique, coacervation, implants, targeted delivery, microencapsulation, and others. The targeted delivery segment is likely to hold the largest revenue share. The segment demand is increasing due to the rising demand along with the increasing geriatric and pediatric population. Additionally, targeted delivery provides the site of action and can aid in allowing drugs to be away from sites that might lead to drug toxicity, as compared to traditional delivery systems.

The market is divided into five categories based on release mechanism: micro reservoir partition controlled drug delivery systems, chemically activated, feedback-regulated drug delivery systems, activation-modulated drug delivery systems, and polymer-based systems. The feedback-regulated drug delivery system is likely to possess the market share owing to therapeutic efficiency in the treatment of disorders including diabetes. Moreover, increasing R&D activities to take benefit of the potential of feedback-regulated controlled drug delivery systems as countermeasures will support market expansion.

The market is divided into six categories based on application: infusion pumps, metered dose inhalers, transdermal & ocular patches, oral controlled-drug delivery systems, inject able, and drug-eluting stents. The oral controlled segment is likely to maintain its dominance during the forecast period owing to its frequent availability and usage. Further, another lucrative segment that is expected to grow during the forecast period is metered dosage inhalers. The increasing prevalence of respiratory disorders, technological advancements, and frequent products are the major factors expected to drive the growth of the segment.

Control Release Drug Delivery Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Control Release Drug Delivery Market- Competitive Landscape:

A wide range of technologies is used by many companies that ensure controlled release. In implementing controlled release major pharmaceutical companies are also indulged to increase product penetration and consumer base. Thus, the market consists of various players from other players and new entrants facing intense competition. Moreover, key participants are indulged in R&D activities, collaboration, mergers & acquisitions, and partnerships to expand their existing product portfolios. For instance, in March 2022, Evonik announced, a new micro particle technology EUDRATEC® SoluFlow in oral drug products to develop the solubility of active pharmaceutical ingredients. Additionally, EUDRATEC SoluFlow makes it possible to develop new oral therapeutics for a variety of conditions, such as cancer, cardiovascular diseases, diabetes, and infectious diseases since more than 70 percent of new small molecules are insoluble.

Recent Developments:

For instance, in January 2021, TAPEMARK AND BIOTTS PARTNER to create MACROPERM™ for large-molecule transdermal drug delivery. Additionally, it is a new large-molecule transdermal technology that is designed to transport API (Active Pharmaceutical Ingredients) through the skin.

Key features of the study:

This proposed research study on control release drug delivery market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.

The report provides the client the latest up-to-date and trending insights about the control release drug delivery market.

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for control release drug delivery market.

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the control release drug delivery market.

Impact of COVID-19 on control release drug delivery market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on control release drug delivery market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the control release drug delivery market, we have also included competitive landscape and key innovator analysis for the control release drug delivery market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the control release drug delivery market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.

The global control release drug delivery market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CONTROL RELEASE DRUG DELIVERY MARKET KEY PLAYERS

  • Adare Pharma Solutions
  • Orbis Biosciences, Inc.
  • Alkermes plc
  • Capsugel
  • Johnson and Johnson
  • Colorcon
  • GlaxoSmithKline
  • Coating Place, Inc.
  • Merck and Co., Inc.
  • Corium International, Inc.
  • Lonza
  • Pfizer, Inc
  • Aradigm Corporation
  • Depomed, Inc.

GLOBALCONTROL RELEASE DRUG DELIVERY MARKET, BY TECHNOLOGY

  • Transdermal
  • Wurster Technique
  • Coacervation
  • Implants
  • Targeted Delivery
  • Micro Encapsulation
  • Others

GLOBAL CONTROL RELEASE DRUG DELIVERY MARKET, BY RELEASE MECHANISM

  • Micro Reservoir Partition Controlled Drug Delivery Systems
  • Chemically Activated
  • Feedback Regulated Drug Delivery Systems
  • Activation-modulated Drug Delivery Systems
  • Polymer Based Systems

GLOBAL CONTROL RELEASE DRUG DELIVERY MARKET, BY APPLICATION

  • Infusion Pumps
  • Metered Dose Inhalers
  • Transdermal & Ocular Patches
  • Oral Controlled-drug delivery Systems
  • Injectable
  • Drug Eluting Stents

GLOBAL CONTROL RELEASE DRUG DELIVERY MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Control Release Drug Delivery Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Control Release Drug Delivery Market Snippet by Technology
    • 2.1.2. Control Release Drug Delivery Market Snippet by Release Mechanism
    • 2.1.3. Control Release Drug Delivery Market Snippet by Application
    • 2.1.4. Control Release Drug Delivery Market Snippet by Country
    • 2.1.5. Control Release Drug Delivery Market Snippet by Region
  • 2.2. Competitive Insights

3. Control Release Drug Delivery Key Market Trends

  • 3.1. Control Release Drug Delivery Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Control Release Drug Delivery Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Control Release Drug Delivery Market Opportunities
  • 3.4. Control Release Drug Delivery Market Future Trends

4. Control Release Drug Delivery Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Control Release Drug Delivery Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Control Release Drug Delivery Market Landscape

  • 6.1. Control Release Drug Delivery Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Control Release Drug Delivery Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2022&2030 (%)
    • 7.1.2. Transdermal
    • 7.1.3. Wurster Technique
    • 7.1.4. Coacervation
    • 7.1.5. Implants
    • 7.1.6. Targeted Delivery
    • 7.1.7. Micro Encapsulation
    • 7.1.8. Others

8. Control Release Drug Delivery Market - By Release Mechanism

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Release Mechanism, 2022&2030 (%)
    • 8.1.2. Micro Reservoir Partition Controlled Drug Delivery Systems
    • 8.1.3. Chemically Activated
    • 8.1.4. Feedback Regulated Drug Delivery Systems
    • 8.1.5. Activation-modulated Drug Delivery Systems
    • 8.1.6. Polymer Based Systems

9. Control Release Drug Delivery Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 9.1.2. Infusion Pumps
    • 9.1.3. Metered Dose Inhalers
    • 9.1.4. Transdermal & Ocular Patches
    • 9.1.5. Oral Controlled-drug delivery Systems
    • 9.1.6. Injectable
    • 9.1.7. Drug Eluting Stents

10. Control Release Drug Delivery Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Control Release Drug Delivery Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Control Release Drug Delivery Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Control Release Drug Delivery Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Control Release Drug Delivery Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Control Release Drug Delivery Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology , 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Release Mechanism, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Control Release Drug Delivery Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Adare Pharma Solutions
    • 11.2.2. Orbis Biosciences, Inc.
    • 11.2.3. Alkermes plc
    • 11.2.4. Capsugel
    • 11.2.5. Johnson and Johnson
    • 11.2.6. Colorcon
    • 11.2.7. GlaxoSmithKline
    • 11.2.8. Coating Place, Inc.
    • 11.2.9. Merck and Co., Inc.
    • 11.2.10. Corium International, Inc.
    • 11.2.11. Lonza
    • 11.2.12. Pfizer, Inc
    • 11.2.13. Aradigm Corporation
    • 11.2.14. Depomed, Inc.
    • 11.2.15. The Danfoss Group

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦